2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Clinical trial NCT06626633 · SUSPENDED

Trial details

NCT number: NCT06626633
Sponsor: University of Maryland, Baltimore
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-08-26
Primary completion: 2025-08-25
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.